Sage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of ...

Cambridge, USA-based biotech Sage Therapeutics yesterday announced that, while rejecting an unsolicited takeover offer, its ...

After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on ...

Sage’s board of directors said Biogen’s offer “undervalues” the company, but will explore other strategic alternatives to ...

Robert Kennedy Jr. indicated he would consider authorizing the government to seize patents of high-priced medicines to lower ...

Anti-abortion groups aren’t lobbying against RFK Jr., U.S. reported first case of H5N9 bird flu strain, Sage Therapeutics ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

You no doubt are familiar with social determinants of health, items such as food security, housing and transportation, and how inadequacy in those areas can affect well-being. But are you aware of ...

Ken Hall analyses two artificial intelligence (AI) stocks as Chinese startup DeepSeek takes the world by storm, and looks at whether he should buy them for his portfolio.

Inhibikase’s setback continues biopharma’s losing streak against Parkinson’s, marked by several clinical failures and ...

UK stocks are slightly higher Thursday morning with investors digesting the latest batch of economic data, and earnings news, besides ...